Marker Therapeutics is Biotechnology in United States that focus on Marker Therapeutics Inc business. Founded in 1992. They cover business area such as Marker Therapeutics Inc, commercialization, innovative peptide-base vaccine, hematological malignancy, solid tumor indication, product candidate, associate antigen, taa, tumor target, tumor cell, those target, peptide-base immunotherapeutic vaccine, metastatic solid tumor, PolyStart.
1992
( 32 years old in 2024 )
Marker Therapeutics Inc
-
3200 Southwest Freeway
Suite 2500
Houston, TX 77027
United States
Private
Marker Therapeutics Inccommercializationinnovative peptide-base vaccinehematological malignancysolid tumor indicationproduct candidateassociate antigentaatumor targettumor cellthose targetpeptide-base immunotherapeutic vaccinemetastatic solid tumorPolyStart
* We use standard office opening hours in near Marker Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Marker Therapeutics is Biotechnology business from United States that founded in 1992 (32 years old in 2024), Marker Therapeutics business is focusing on Marker Therapeutics Inc.
Marker Therapeutics headquarter office and corporate office address is located in 3200 Southwest Freeway Suite 2500 Houston, TX 77027 United States.
Marker Therapeutics was founded in United States.
In 2024, Marker Therapeutics is currently focus on Marker Therapeutics Inc sector.
Above is snippet of Google Trends for "Marker Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Marker Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
